Titre : Antithrombiniques

Antithrombiniques : Questions médicales fréquentes

Termes MeSH sélectionnés :

RNA, Long Noncoding
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Antithrombiniques : Questions médicales les plus fréquentes", "headline": "Antithrombiniques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Antithrombiniques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-27", "dateModified": "2025-04-22", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Antithrombiniques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Anticoagulants", "url": "https://questionsmedicales.fr/mesh/D000925", "about": { "@type": "MedicalCondition", "name": "Anticoagulants", "code": { "@type": "MedicalCode", "code": "D000925", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.119" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Inhibiteurs du facteur Xa", "alternateName": "Factor Xa Inhibitors", "url": "https://questionsmedicales.fr/mesh/D065427", "about": { "@type": "MedicalCondition", "name": "Inhibiteurs du facteur Xa", "code": { "@type": "MedicalCode", "code": "D065427", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.505.954.502.119.500.500" } } } ], "about": { "@type": "MedicalCondition", "name": "Antithrombiniques", "alternateName": "Antithrombins", "code": { "@type": "MedicalCode", "code": "D000991", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Vicente Vicente", "url": "https://questionsmedicales.fr/author/Vicente%20Vicente", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain." } }, { "@type": "Person", "name": "Javier Corral", "url": "https://questionsmedicales.fr/author/Javier%20Corral", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain." } }, { "@type": "Person", "name": "Irene Martínez-Martínez", "url": "https://questionsmedicales.fr/author/Irene%20Mart%C3%ADnez-Mart%C3%ADnez", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, U-765, Center for Biomedical Research on Rare Diseases, Murcia, Spain. Electronic address: immlgi@um.es." } }, { "@type": "Person", "name": "Belén de la Morena-Barrio", "url": "https://questionsmedicales.fr/author/Bel%C3%A9n%20de%20la%20Morena-Barrio", "affiliation": { "@type": "Organization", "name": "Servicio de Hematología y Oncología Médica, Hospital Universitario Morales Meseguer, Centro Regional de Hemodonación, Universidad de Murcia, IMIB-Arrixaca, CIBERER, Murcia, Spain." } }, { "@type": "Person", "name": "Zsuzsanna Bereczky", "url": "https://questionsmedicales.fr/author/Zsuzsanna%20Bereczky", "affiliation": { "@type": "Organization", "name": "Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Evaluation of rRNA depletion methods for capturing the RNA virome from environmental surfaces.", "datePublished": "2023-07-07", "url": "https://questionsmedicales.fr/article/37420286", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13104-023-06417-9" } }, { "@type": "ScholarlyArticle", "name": "The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37391042", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.eprac.2023.05.005" } }, { "@type": "ScholarlyArticle", "name": "MATR3-antisense LINE1 RNA meshwork scaffolds higher-order chromatin organization.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37381832", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.15252/embr.202357550" } }, { "@type": "ScholarlyArticle", "name": "Leveraging Small Molecule-Induced Aptazyme Cleavage for Directed A-to-I RNA Editing.", "datePublished": "2023-06-29", "url": "https://questionsmedicales.fr/article/37384927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1021/acssynbio.3c00038" } }, { "@type": "ScholarlyArticle", "name": "Gene Expression in Synovium of Rotator Cuff Tear Patients Determined by RNA Sequencing.", "datePublished": "2023-06-28", "url": "https://questionsmedicales.fr/article/37380850", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s10528-023-10411-y" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Actions pharmacologiques", "item": "https://questionsmedicales.fr/mesh/D020228" }, { "@type": "ListItem", "position": 4, "name": "Utilisations thérapeutiques", "item": "https://questionsmedicales.fr/mesh/D045506" }, { "@type": "ListItem", "position": 5, "name": "Agents hématologiques", "item": "https://questionsmedicales.fr/mesh/D006401" }, { "@type": "ListItem", "position": 6, "name": "Anticoagulants", "item": "https://questionsmedicales.fr/mesh/D000925" }, { "@type": "ListItem", "position": 7, "name": "Antithrombiniques", "item": "https://questionsmedicales.fr/mesh/D000991" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Antithrombiniques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Antithrombiniques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Antithrombiniques", "description": "Comment diagnostiquer une thrombose ?\nQuels tests pour évaluer l'anticoagulation ?\nQuels symptômes indiquent une embolie ?\nComment détecter une insuffisance veineuse ?\nQuels signes cliniques d'une thrombose veineuse ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Antithrombiniques", "description": "Quels sont les symptômes d'une thrombose ?\nComment reconnaître une embolie pulmonaire ?\nQuels symptômes d'une hémorragie ?\nQuels signes d'une thrombopénie ?\nComment se manifeste une crise thromboembolique ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Antithrombiniques", "description": "Comment prévenir les thromboses ?\nQuels conseils pour les patients à risque ?\nComment utiliser les bas de compression ?\nQuels aliments éviter pour prévenir les caillots ?\nComment gérer les facteurs de risque ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Antithrombiniques", "description": "Quels médicaments sont des antithrombiniques ?\nComment administrer l'héparine ?\nQuels sont les effets secondaires des anticoagulants ?\nComment surveiller l'efficacité des anticoagulants ?\nQuels traitements pour la thrombose veineuse ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Antithrombiniques", "description": "Quelles sont les complications des anticoagulants ?\nQuels risques d'une surdose d'anticoagulants ?\nComment gérer une hémorragie sous anticoagulants ?\nQuelles sont les complications de la thrombose ?\nQuels effets à long terme des anticoagulants ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Antithrombiniques", "description": "Quels sont les facteurs de risque de thrombose ?\nComment l'âge influence-t-il le risque ?\nQuel rôle joue le tabagisme ?\nComment les maladies chroniques affectent-elles le risque ?\nQuel impact a la grossesse sur le risque ?", "url": "https://questionsmedicales.fr/mesh/D000991?mesh_terms=RNA,+Long+Noncoding&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une thrombose ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic de thrombose se fait par échographie, D-dimères et examens cliniques." } }, { "@type": "Question", "name": "Quels tests pour évaluer l'anticoagulation ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent le temps de prothrombine (TP) et l'INR pour surveiller l'anticoagulation." } }, { "@type": "Question", "name": "Quels symptômes indiquent une embolie ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur thoracique, essoufflement et toux avec sang." } }, { "@type": "Question", "name": "Comment détecter une insuffisance veineuse ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'insuffisance veineuse se détecte par examen physique et Doppler veineux." } }, { "@type": "Question", "name": "Quels signes cliniques d'une thrombose veineuse ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent œdème, rougeur, chaleur et douleur au niveau de la jambe." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une thrombose ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent douleur, gonflement, rougeur et chaleur dans la zone affectée." } }, { "@type": "Question", "name": "Comment reconnaître une embolie pulmonaire ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent douleur thoracique aiguë, essoufflement et tachycardie." } }, { "@type": "Question", "name": "Quels symptômes d'une hémorragie ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent saignements inhabituels, ecchymoses et fatigue excessive." } }, { "@type": "Question", "name": "Quels signes d'une thrombopénie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent des saignements fréquents, des ecchymoses et des pétéchies." } }, { "@type": "Question", "name": "Comment se manifeste une crise thromboembolique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par une douleur soudaine, un essoufflement et une cyanose." } }, { "@type": "Question", "name": "Comment prévenir les thromboses ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut l'exercice régulier, l'hydratation et l'évitement de la sédentarité." } }, { "@type": "Question", "name": "Quels conseils pour les patients à risque ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les patients à risque doivent suivre un traitement anticoagulant et éviter les voyages longs." } }, { "@type": "Question", "name": "Comment utiliser les bas de compression ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Les bas de compression aident à améliorer la circulation et à réduire le risque de thrombose." } }, { "@type": "Question", "name": "Quels aliments éviter pour prévenir les caillots ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments riches en vitamine K comme les légumes à feuilles vertes si sous anticoagulants." } }, { "@type": "Question", "name": "Comment gérer les facteurs de risque ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Gérer les facteurs de risque inclut le contrôle du poids, l'arrêt du tabac et le traitement des maladies chroniques." } }, { "@type": "Question", "name": "Quels médicaments sont des antithrombiniques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antithrombiniques incluent l'héparine, la warfarine et les nouveaux anticoagulants." } }, { "@type": "Question", "name": "Comment administrer l'héparine ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "L'héparine est administrée par injection sous-cutanée ou intraveineuse selon les besoins." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des anticoagulants ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent saignements, ecchymoses et réactions allergiques." } }, { "@type": "Question", "name": "Comment surveiller l'efficacité des anticoagulants ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité se surveille par des tests sanguins réguliers comme l'INR et le temps de prothrombine." } }, { "@type": "Question", "name": "Quels traitements pour la thrombose veineuse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent anticoagulants, compression et parfois intervention chirurgicale." } }, { "@type": "Question", "name": "Quelles sont les complications des anticoagulants ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent hémorragies, thrombopénie et interactions médicamenteuses." } }, { "@type": "Question", "name": "Quels risques d'une surdose d'anticoagulants ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une surdose peut entraîner des saignements graves et nécessite une attention médicale immédiate." } }, { "@type": "Question", "name": "Comment gérer une hémorragie sous anticoagulants ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "En cas d'hémorragie, il faut arrêter l'anticoagulant et consulter un médecin rapidement." } }, { "@type": "Question", "name": "Quelles sont les complications de la thrombose ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'embolie pulmonaire, le syndrome post-thrombotique et la douleur chronique." } }, { "@type": "Question", "name": "Quels effets à long terme des anticoagulants ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les effets à long terme peuvent inclure des saignements récurrents et des problèmes de coagulation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de thrombose ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'obésité, l'immobilité, les antécédents familiaux et certaines maladies." } }, { "@type": "Question", "name": "Comment l'âge influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le risque de thrombose augmente avec l'âge en raison de la diminution de la circulation sanguine." } }, { "@type": "Question", "name": "Quel rôle joue le tabagisme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme augmente le risque de thrombose en favorisant l'inflammation et la coagulation." } }, { "@type": "Question", "name": "Comment les maladies chroniques affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les maladies chroniques comme le diabète et l'hypertension augmentent le risque de thrombose." } }, { "@type": "Question", "name": "Quel impact a la grossesse sur le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "La grossesse augmente le risque de thrombose en raison des changements hormonaux et circulatoires." } } ] } ] }

Sources (10000 au total)

Evaluation of rRNA depletion methods for capturing the RNA virome from environmental surfaces.

Metatranscriptomic analysis of RNA viromes on built-environment surfaces is hampered by low RNA yields and high abundance of rRNA. Therefore, we evaluated the quality of libraries, efficiency of rRNA ... Good-quality RNA libraries were obtained from 0.1 ng of mock community and table surface RNA by changing the adapter concentration and number of PCR cycles. Differences in the target species of the rR...

The Incidence of Graves' Hyperthyroidism Before and After COVID-19 Messenger RNA Vaccination.

Case reports of postvaccine early-onset Graves' hyperthyroidism (PVGD) after the administration of COVID-19 vaccination have emerged. Our aim was to investigate whether the incidence of Graves' hypert... We compared the incidence of new-onset GD at a single academic center during 2 periods: December 2017 to October 2019 and December 2020 to October 2022, ie, before and after the implementation of COVI... During the prevaccination period, 803 patients carried diagnoses of GD, and of these, 131 were new. During the postvaccination period, 901 patients carried diagnoses of GD, and of these, 138 were new.... There was no increase in new-onset GD after COVID-19 vaccination. Median free T4 was higher in patients with PVGD, but this was not statistically significant....